• Open Access

Scientific Opinion on the substantiation of health claims related to zinc and function of the immune system (ID 291, 1757), DNA synthesis and cell division (ID 292, 1759), protection of DNA, proteins and lipids from oxidative damage (ID 294, 1758), maintenance of bone (ID 295, 1756), cognitive function (ID 296), fertility and reproduction (ID 297, 300), reproductive development (ID 298), muscle function (ID 299), metabolism of fatty acids (ID 302), maintenance of joints (ID 305), function of the heart and blood vessels (ID 306), prostate function (ID 307), thyroid function (ID 308), acid-base metabolism (ID 360), vitamin A metabolism (ID 361) and maintenance of vision (ID 361) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Authors

  • EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)


  • Panel members: Jean-Louis Bresson, Albert Flynn, Marina Heinonen, Karin Hulshof, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Hildegard Przyrembel, Seppo Salminen, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Henk van den Berg, Hendrik van Loveren and Hans Verhagen
  • Correspondence: nda@efsa.europa.eu
  • Adoption date: 2 July 2009
  • Published date: 1 October 2009
  • Question number: EFSA-Q-2008-1078, EFSA-Q-2008-1079, EFSA-Q-2008-1081, EFSA-Q-2008-1082, EFSA-Q-2008-1083, EFSA-Q-2008-1084, EFSA-Q-2008-1085, EFSA-Q-2008-1086, EFSA-Q-2008-1087, EFSA-Q-2008-1089, EFSA-Q-2008-1092, EFSA-Q-2008-1093, EFSA-Q-2008-1094, EFSA-Q-2008-1095, EFSA-Q-2008-1147, EFSA-Q-2008-1148, EFSA-Q-2008-2489, EFSA-Q-2008-2490, EFSA-Q-2008-2491, EFSA-Q-2008-2492
  • On request from: European Commission

Ancillary